[Bufodienolide nature of endogenous inhibitor of human sodium-potassium adenosine triphosphatase].
Dmitrieva
R I
RI
Georgiev
I Iu
IIu
Shpen'
V M
VM
Bagrov
A Ia
AIa
D000818:Animals; D002018:Bufanolides / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine; D002025:Bufonidae; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D009203:Myocardial Infarction / Q000097:blood / Q000652:urine; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*
D002018:Bufanolides; C093896:marinobufagenin; D000254:Sodium-Potassium-Exchanging ATPase
Bufodienolidnaia priroda éndogennogo ingibitora natriĭ-kalievoĭ adenozintrifosfatazy cheloveka.